Latest News and Press Releases
Want to stay updated on the latest news?
-
WAUKEGAN, Ill., April 09, 2026 (GLOBE NEWSWIRE) -- NSTS Bancorp, Inc. (the “Company”), the holding company for North Shore Trust and Savings (the “Bank”), announced today the recent passing of...
-
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first...
-
SANTA CLARA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation (Nasdaq: SITM), the Precision Timing company, will announce its first quarter 2026 financial results on Wednesday, May 6,...
-
MENLO PARK, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2026 financial results for the period ended...
-
WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of...
-
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Binah Capital Group (NASDAQ: BCG) (“Binah” or the “Company”) today announced that Christopher Motta has been promoted to President of World Equity Group...
-
HOUSTON , April 09, 2026 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc (Nasdaq: SKWD) (“Skyward Group” or “the Company”), expects to issue its first quarter 2026 earnings, inclusive of...
-
AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that...
-
SANTA BARBARA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its first quarter 2026 financial results after the close of the U.S....
-
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for...